MCID: PNM007
MIFTS: 71

Pneumonia

Categories: Infectious diseases, Respiratory diseases

Aliases & Classifications for Pneumonia

MalaCards integrated aliases for Pneumonia:

Name: Pneumonia 12 76 29 55 6 43 3 3 44 15 63 63 73
Acute Pneumonia 12 73
Doid:552 15

Classifications:



External Ids:

Disease Ontology 12 DOID:552
MeSH 44 D011014
NCIt 50 C3333
SNOMED-CT 68 60363000

Summaries for Pneumonia

MedlinePlus : 43 Pneumonia is an infection in one or both of the lungs. Many germs, such as bacteria, viruses, and fungi, can cause pneumonia. You can also get pneumonia by inhaling a liquid or chemical. People most at risk are older than 65 or younger than 2 years of age, or already have health problems. Symptoms of pneumonia vary from mild to severe. See your doctor promptly if you Have a high fever Have shaking chills Have a cough with phlegm that doesn't improve or gets worse Develop shortness of breath with normal daily activities Have chest pain when you breathe or cough Feel suddenly worse after a cold or the flu Your doctor will use your medical history, a physical exam, and lab tests to diagnose pneumonia. Treatment depends on what kind you have. If bacteria are the cause, antibiotics should help. If you have viral pneumonia, your doctor may prescribe an antiviral medicine to treat it. Preventing pneumonia is always better than treating it. Vaccines are available to prevent pneumococcal pneumonia and the flu. Other preventive measures include washing your hands frequently and not smoking. NIH: National Heart, Lung, and Blood Institute

MalaCards based summary : Pneumonia, also known as acute pneumonia, is related to mycoplasma pneumoniae pneumonia and bacterial pneumonia, and has symptoms including fever, pruritus and hemoptysis. An important gene associated with Pneumonia is LINC02258 (Long Intergenic Non-Protein Coding RNA 2258), and among its related pathways/superpathways are Innate Immune System and PEDF Induced Signaling. The drugs Augmentin and Avelox I.V. have been mentioned in the context of this disorder. Affiliated tissues include lung, testes and skin, and related phenotypes are hematopoietic system and immune system

Disease Ontology : 12 A lung disease that involves lung parenchyma or alveolar inflammation and abnormal alveolar filling with fluid (consolidation and exudation). It results from a variety of causes including infection with bacteria, viruses, fungi or parasites, and chemical or physical injury to the lungs. It is accompanied by fever, chills, cough, and difficulty in breathing.

CDC : 3 Pneumocystis jirovecii in the lung of an HIV/AIDS patient.

PubMed Health : 63 About pneumonia: Pneumonia (nu-MO-ne-ah) is an infection in one or both of the lungs. Many germs—such as bacteria, viruses, and fungi—can cause pneumonia.The infection inflames your lungs' air sacs, which are called alveoli (al-VEE-uhl-eye). The air sacs may fill up with fluid or pus, causing symptoms such as a cough with phlegm (a slimy substance), fever, chills, and trouble breathing.

Wikipedia : 76 Pneumonia is an inflammatory condition of the lung affecting primarily the small air sacs known as... more...

Related Diseases for Pneumonia

Diseases in the Pneumonia family:

Viral Pneumonia Bacterial Pneumonia

Diseases related to Pneumonia via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 1280)
# Related Disease Score Top Affiliating Genes
1 mycoplasma pneumoniae pneumonia 34.4 CRP IL10 IL6 TLR2 TNF
2 bacterial pneumonia 34.1 CRP CXCL8 ELANE IL6 SFTPD TLR4
3 idiopathic interstitial pneumonia 33.8 CCL2 CXCL8 ELANE MUC5B SFTPC SFTPD
4 pneumocystosis 33.3 CD40LG SFTPD TNF
5 pulmonary fibrosis, idiopathic 33.0 CCL2 CXCL8 ELANE IL1B MUC5B SFTPC
6 bronchiolitis obliterans 32.6 CXCL8 IL10 IL6 TNF
7 avian influenza 32.4 CXCL8 IL6 SFTPD TNF
8 q fever 32.4 IL10 IL1B IL6 TLR2 TLR4 TNF
9 bronchiolitis 32.2 CRP CXCL8 IL10 IL6 MUC5B TLR4
10 legionellosis 32.1 IL1B TLR2 TLR4 TLR5 TNF
11 pulmonary hemosiderosis 32.1 CRP MPO MUC5B
12 invasive aspergillosis 32.0 CXCL8 SFTPD TLR2 TLR4
13 melioidosis 32.0 IL10 IL6 TLR2 TLR4 TLR5 TNF
14 respiratory failure 32.0 CRP CXCL8 ELANE SFTPC SFTPD TNF
15 adult respiratory distress syndrome 31.9 CXCL8 ELANE IL10 IL6 SFTPC TNF
16 common variable immunodeficiency 31.9 CD40LG IL10 IL6 TLR2 TNF
17 extrinsic allergic alveolitis 31.9 CCL2 CXCL8 IL10 IL1B IL6 MPO
18 irak4 deficiency 31.8 TLR2 TLR4 TLR5
19 myd88 deficiency 31.8 TLR2 TLR4 TLR5
20 toxic shock syndrome 31.7 CXCL8 IL10 IL1B IL6 TLR2 TLR4
21 interstitial lung disease 31.7 CCL2 CXCL8 IL10 IL1B IL6 MUC5B
22 chlamydia 31.5 CRP CXCL8 IL10 IL1B IL6 TLR2
23 viral infectious disease 31.5 CD40LG CXCL8 IL10 IL1B IL6 TNF
24 lung disease 31.3 CCL2 CXCL8 ELANE IL10 IL1B IL6
25 bronchitis 31.2 CRP CXCL8 ELANE MPO TNF
26 haemophilus influenzae 31.1 CXCL8 IL1B TLR2 TNF
27 acquired immunodeficiency syndrome 30.9 IL10 IL1B IL6 TNF
28 human immunodeficiency virus infectious disease 30.9 IL10 IL6 TNF
29 arthritis 30.9 CCL2 CXCL8 IL10 IL1B IL6 TNF
30 pulmonary fibrosis 30.8 CCL2 IL1B MUC5B SFTPC SFTPD
31 meningitis 30.7 CCL2 CRP CXCL8 IL10 IL1B IL6
32 purpura 30.7 CRP IL6 TNF
33 fasciitis 30.7 CXCL8 IL6 TNF
34 pulmonary tuberculosis 30.7 IL10 TLR2 TNF
35 hematopoietic stem cell transplantation 30.7 IL10 IL6 TNF
36 connective tissue disease 30.7 CD40LG IL10 IL6 SFTPD TNF
37 lupus erythematosus 30.7 CD40LG IL10 TLR5 TNF
38 arteries, anomalies of 30.6 CCL2 CRP IL1B IL6 TNF
39 myocarditis 30.6 CD40LG IL6 TNF
40 otitis media 30.6 CXCL8 IL10 IL1B IL6 MUC5B TLR2
41 pericarditis 30.6 CRP IL1B IL6 TNF
42 spondylitis 30.5 CRP IL6 TNF
43 duodenal ulcer 30.5 CXCL8 IL1B TNF
44 acute cystitis 30.5 CCL2 CRP CXCL8 IL6
45 spondyloarthropathy 1 30.5 CRP TLR4 TNF
46 pulmonary alveolar proteinosis 30.4 CCL2 SFTPC SFTPD
47 transverse myelitis 30.4 CXCL8 IL10 IL6 TNF
48 septic arthritis 30.4 CRP CXCL8 TLR2 TLR4
49 rheumatoid arthritis 30.4 CCL2 CD40LG CRP CXCL8 IL10 IL1B
50 heart disease 30.4 CRP CXCL8 IL10 IL1B IL6 TNF

Graphical network of the top 20 diseases related to Pneumonia:



Diseases related to Pneumonia

Symptoms & Phenotypes for Pneumonia

UMLS symptoms related to Pneumonia:


fever, pruritus, hemoptysis, snoring, coughing

MGI Mouse Phenotypes related to Pneumonia:

46
# Description MGI Source Accession Score Top Affiliating Genes
1 hematopoietic system MP:0005397 10.25 CD40LG CSF3 ELANE IL10 IL1B IL6
2 immune system MP:0005387 10.25 CCL2 CD40LG CRP CSF3 ELANE IL10
3 homeostasis/metabolism MP:0005376 10.21 CD40LG CRP ELANE IL10 IL1B IL6
4 cardiovascular system MP:0005385 10.17 CD40LG CRP IL10 IL1B IL6 MPO
5 mortality/aging MP:0010768 9.97 CD40LG ELANE IL10 IL1B IL6 MPO
6 integument MP:0010771 9.86 CD40LG CSF3 IL10 IL1B IL6 TLR2
7 neoplasm MP:0002006 9.61 ELANE IL10 IL1B IL6 SFTPC TLR2
8 respiratory system MP:0005388 9.28 IL10 IL6 MUC5B SFTPC SFTPD TLR2

Drugs & Therapeutics for Pneumonia

PubMedHealth treatment related to Pneumonia: 63

Treatment for pneumonia depends on the type of pneumonia you have and how severe it is. Most people who have community-acquired pneumonia—the most common type of pneumonia—are treated at home.The goals of treatment are to cure the infection and prevent complications.

FDA approved drugs:

(show all 7)
# Drug Name Active Ingredient(s) 18 Company Approval Date
1
Augmentin 18 AMOXICILLIN; CLAVULANATE POTASSIUM SmithKline Beecham February 1996
2
Avelox I.V. 18 MOXIFLOXACIN HYDROCHLORIDE Bayer November 2001
3
Teflaro 18 CEFTAROLINE FOSAMIL Cerexa Nov-10
4
Tequin 18 Bristol-Myers Squibb December, 1999
5
Tygacil 18 TIGECYCLINE Wyeth 2005
6
Vibativ 18 * TELAVANCIN * TELAVANCIN HYDROCHLORIDE Theravance June 2013
7
Zosyn 18 PIPERACILLIN SODIUM; TAZOBACTAM SODIUM Wyeth May 1996

Drugs for Pneumonia (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 1055)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Vancomycin Approved Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable,Early Phase 1 1404-90-6 14969 441141
2
Tobramycin Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 32986-56-4 36294 5496
3
Levofloxacin Approved, Investigational Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable 100986-85-4 149096
4
Ofloxacin Approved Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable 82419-36-1 4583
5
Azithromycin Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 83905-01-5 55185 447043
6
Salmon Calcitonin Approved, Investigational Phase 4,Phase 2,Phase 3,Not Applicable 47931-85-1 16129616
7
Linezolid Approved, Investigational Phase 4,Phase 3,Phase 2,Not Applicable 165800-03-3 441401
8
Amoxicillin Approved, Vet_approved Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable 26787-78-0 33613
9
Methylprednisolone Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 83-43-2 6741
10
Prednisolone Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 50-24-8 5755
11
Methylprednisolone hemisuccinate Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 2921-57-5
12
Prednisolone phosphate Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 302-25-0
13
Cilastatin Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 82009-34-5 6435415 5280454
14
Imipenem Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 74431-23-5, 64221-86-9 104838
15
Moxifloxacin Approved, Investigational Phase 4,Phase 3,Phase 2,Not Applicable 354812-41-2, 151096-09-2 152946
16
Polyestradiol phosphate Approved Phase 4,Phase 3,Phase 2,Not Applicable 28014-46-2
17
Ethinyl Estradiol Approved Phase 4,Phase 3,Phase 2,Not Applicable 57-63-6 5991
18
Metronidazole Approved Phase 4,Phase 3,Phase 2,Not Applicable 443-48-1 4173
19
Estradiol Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 2,Not Applicable 50-28-2 5757
20
Norgestimate Approved, Investigational Phase 4,Phase 3,Phase 2,Not Applicable 35189-28-7 6540478
21 Estradiol valerate Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 2,Not Applicable 979-32-8
22
Ethanol Approved Phase 4,Phase 3,Phase 2,Not Applicable,Early Phase 1 64-17-5 702
23
Chlorhexidine Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 55-56-1 2713 9552079
24
Oseltamivir Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 204255-11-8, 196618-13-0 65028
25
Colistin Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 1264-72-8, 1066-17-7 5311054
26
Prednisone Approved, Vet_approved Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable 53-03-2 5865
27
Calcium Carbonate Approved, Investigational Phase 4 471-34-1
28
Miconazole Approved, Investigational, Vet_approved Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable 22916-47-8 4189
29
Cyclophosphamide Approved, Investigational Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable 6055-19-2, 50-18-0 2907
30
Ganciclovir Approved, Investigational Phase 4,Phase 1,Phase 2,Not Applicable 82410-32-0 3454
31
Acyclovir Approved Phase 4,Phase 3,Phase 2 59277-89-3 2022
32
Ciprofloxacin Approved, Investigational Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable 85721-33-1 2764
33
Tazobactam Approved Phase 4,Phase 2,Phase 3,Phase 1 89786-04-9 123630
34
Penicillin G Approved, Vet_approved Phase 4,Phase 3 61-33-6 5904
35
Piperacillin Approved Phase 4,Phase 2,Phase 3 66258-76-2 43672
36
Clarithromycin Approved Phase 4,Phase 3,Phase 2 81103-11-9 84029
37
Cefuroxime Approved Phase 4,Phase 3,Phase 2,Not Applicable 55268-75-2 5361202 5479529
38
Trimethoprim Approved, Vet_approved Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable 738-70-5 5578
39
Sulfamethoxazole Approved Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable 723-46-6 5329
40
Bosentan Approved, Investigational Phase 4,Phase 3,Phase 2 147536-97-8 104865
41 Strawberry Approved Phase 4,Phase 3
42
Fluticasone Approved, Experimental Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 90566-53-3 62924
43
Cefotaxime Approved Phase 4,Phase 3,Phase 2,Not Applicable 63527-52-6 456256 5742673
44
Cefoxitin Approved Phase 4,Phase 2 35607-66-0 441199
45
Omeprazole Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1 73590-58-6 4594
46
Budesonide Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 51333-22-3 63006 5281004
47 Beractant Approved Phase 4 108778-82-1
48
Sevoflurane Approved, Vet_approved Phase 4,Phase 1,Phase 2,Not Applicable 28523-86-6 5206
49 tannic acid Approved Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable,Early Phase 1
50
Rocuronium Approved Phase 4,Not Applicable 119302-91-9, 143558-00-3 441290

Interventional clinical trials:

(show top 50) (show all 3542)
# Name Status NCT ID Phase Drugs
1 Ventilator Associated Pneumonia in Taper Guard Versus Normal Tube in ICU Patients Unknown status NCT01501227 Phase 4
2 Aerosolized Antibiotics in the Treatment of Ventilator Associated Pneumonia Unknown status NCT02478710 Phase 4 Aerosolized Tobramycin or Vancomycin;Aerosolized Placebo
3 Clinical Pathway Based on Procalcitonin Levels for the Management of Community-acquired Pneumonia in Outpatients Unknown status NCT02600806 Phase 4 Azithromycin;Levofloxacin
4 Pharmacokinetic and Pharmacodynamic Evaluation of Linezolid Administered Intravenously in MRSA-positive, Morbidly Obese Patients With Pneumonia Unknown status NCT01805284 Phase 4 Linezolid
5 Trial on the Ideal Duration of Oral Antibiotics in Children With Pneumonia Unknown status NCT02258763 Phase 4 Amoxicillin-Potassium Clavulanate Combination;Placebo
6 Corticosteroid Therapy for Severe Community-Acquired Pneumonia Unknown status NCT02552342 Phase 4 methylprednisolone;Normal saline
7 Addition of Tobramycin Inhalation in the Treatment of Ventilator Associated Pneumonia Unknown status NCT02440828 Phase 4 tobramycin inhalation;placebo
8 Probiotics for Prevention of Ventilator-Associated Pneumonia (VAP) Unknown status NCT01301131 Phase 4
9 Duration of Antibiotic Therapy in Community - Acquired Pneumonia Unknown status NCT01492387 Phase 4
10 Ventilator-associated Pneumonia (VAP) and Humidification System Unknown status NCT01546974 Phase 4
11 Linezolid Alone or Combined With Carbapenem Against Methicillin-resistant Staphylococcus Aureus (MRSA) in Ventilator-associated Pneumonia Unknown status NCT01356472 Phase 4 Imipenem/cilastatin
12 Efficacy and Safety Trial to Assess Moxifloxacin in Treating Community-Acquired Pneumonia (CAP) With Aspiration Factors Unknown status NCT00752947 Phase 4 moxifloxacin;levofloxacin;metronidazole
13 Chlorhexidine Gluconate for Prevention of Ventilator Associated Pneumonia in Children. Unknown status NCT01883596 Phase 4 0.12% chlorhexidine solution;Placebo
14 Chinese Medicinal Herbs Treatment on Novel Influenza A (H1N1)Pneumonia: Multi-centre, Prospective, Randomized Controlled Study Unknown status NCT00936013 Phase 4 oseltamivir;oseltamivir and chinese medicinal herbs
15 SDD for Eradicating CRKP Carriage Unknown status NCT01761487 Phase 4
16 Cyclosporine A in the TReatment of Interstitial Pneumonitis Associated With Sjogren's Syndrome Unknown status NCT02370550 Phase 4 Cyclosporin A;Prednisone;Placebo;Calcium carbonate D
17 PTH - Preemptive Treatment for Herpesviridae Unknown status NCT02152358 Phase 4 Aciclovir;Ganciclovir;Placebo
18 7-valent Pneumococcal Conjugated Vaccination Unknown status NCT00885625 Phase 4
19 Procalcitonin as a Marker of Antibiotic Therapy in Patients With Lower Respiratory Tract Infections Unknown status NCT02171338 Phase 4
20 Lactobacillus Preparation on the Incidence of Diarrhea Unknown status NCT01792739 Phase 4 Lactobacillus casei variety rhamnosus granules;Placebo
21 Effect of Vitamin D Supplementation in Young South African Children Hospitalized With Acute Lower Respiratory Infection Unknown status NCT02054182 Phase 4 Vitamin D
22 Testing if BCG (Bacille Calmette-Guérin) Vaccination Can Induce Innate Immune Training in Adult People Above 50 Years of Age in Guinea-Bissau Unknown status NCT02953327 Phase 4
23 Pneumonia Vaccine in Liver Transplant Recipients: a Booster Strategy Using a Conjugate Vaccine Unknown status NCT00152802 Phase 4
24 Optimizing Influenza Vaccination in Surgical Oncology Patients Unknown status NCT01698177 Phase 4
25 Cotrimoxazole Prophylaxis Cessation Study Among Stabilized HIV-Infected Adult Patients on HAART in Entebbe, Uganda Unknown status NCT00674921 Phase 4 cotrimoxazole;Placebo
26 Safety and Efficacy Study of High Dose Colistin Unknown status NCT02162966 Phase 4 High Dose Colistin;Standard Dose Colistin
27 Bosentan in Pulmonary Hypertension in Interstitial Lung Disease Treatment Study Unknown status NCT00637065 Phase 4 Bosentan;Placebo
28 Middle Meatal Bacteriology During Acute Respiratory Infection in Children Unknown status NCT00545961 Phase 4 placebo;amoxicillin clavulanate acid
29 Comparing Treatment Efficacy With HD/MD Flu Plus Sal in Chronic Obstructive Pulmonary Disease (COPD) Patients Unknown status NCT01131806 Phase 4 fluticasone/ salmeterol 125/25 mcg/puff;fluticasone/ salmeterol 250/25 mcg/puff
30 LGG for Prevention of Infectious Complications During PPI Treatment in Children Unknown status NCT01782118 Phase 4
31 Empirical vs 2nd Line Antibiotic Therapy in Health-care Associated Infections in Cirrhosis Unknown status NCT01820026 Phase 4 Imipenem;Vancomycin;azithromycin;Cefotaxime;Amoxicillin
32 Randomized, Double Blind, Placebo Control Trial to Evaluate the Efficacy of Wu-Chu-Yu Tang on Gastroesophageal Reflux Disease (GERD) Unknown status NCT01822106 Phase 4
33 Prevention of Chronic Lung Disease (CLD) in Preterm Infants Unknown status NCT00883532 Phase 4 budesonide;surfactant and air (placebo)
34 Recovery of Muscle Function After Deep Neuromuscular Block by Means of Diaphragm Ultrasonography Unknown status NCT02698969 Phase 4 Sugammadex;Neostigmine;Atropine;Rocuronium;Fentanyl;Propofol;Sevoflurane
35 Influence of Moderate Inspired Oxygen Fraction (FiO2) and Protective Ventilation on Postoperative Pulmonary Complication Unknown status NCT02198625 Phase 4
36 Comparative Study of Non-Invasive Mask Ventilation vs Cuirass Ventilation in Patients With Acute Respiratory Failure. Unknown status NCT00331656 Phase 4
37 Efficacy of Nebulized Pulmicort Respules in Primary Lung Cancer Patients With COPD Unknown status NCT02504801 Phase 4 Budesonide
38 Effects of Neuromuscular Blocking Agents (NMBA) on the Alteration of Transpulmonary Pressures at the Early Phase of Acute Respiratory Distress Syndrome (ARDS) Unknown status NCT01573715 Phase 4 NIMBEX;NIMBEX
39 Comparing Treatment Efficacy With High and Medium Dose of Fluticasone in Combination With Salmeterol in COPD Patients Unknown status NCT01657487 Phase 4 Fluticasone/Salmeterol high dose
40 Effect of Enteral Genistein Supplementation in Sepsis Unknown status NCT02796794 Phase 4
41 Polysaccharide Antibody Response Study Unknown status NCT02429531 Phase 4
42 Influence of BCG on TDaP-IPV Vaccination Unknown status NCT02771782 Phase 4
43 Effect of Daily Nicotine Patch Application on Mechanical Ventilation Weaning in Smoking Patients Unknown status NCT01104896 Phase 4 Nicotine patch;Placebo
44 Diverticulitis: Antibiotics or Close Observation? Unknown status NCT01111253 Phase 4 Amoxicillin-clavulanate
45 A Study of Residual Curarization Incidence in China Unknown status NCT01690338 Phase 4 Vecuronium Bromide;Rocuronium;Cisatracurium
46 Acute Effect of Sildenafil on Exercise Tolerance and Functional Capacity in COPD, IPF and Post Pneumonectomy Patients Unknown status NCT01382368 Phase 4 Sildenafil
47 Comparisons of Inhaled LAMA or ICS+LABA for COPD With Bronchiectasis Unknown status NCT02546297 Phase 4 Symbicort;Tiotropium Bromide
48 Correlation Among Sperm DNA Fragmentation, Genitourinary Infection by Mycoplasma in Male and the Pregnancy Outcomes After IUI in Their Partner Unknown status NCT01555047 Phase 4
49 Treatment of Intracranial Hypertension of Severe Tramatic Brain Injured Patients. Physiopathologic Effects of Neuromuscular Blocking Agents Unknown status NCT02404779 Phase 4 cisatracurium besilate
50 Time to Eradication of Mycoplasma Genitalium and Chlamydia Trachomatis After Treatment Commenced Unknown status NCT01661985 Phase 4 Azithromycin;Doxycycline;lymecycline

Search NIH Clinical Center for Pneumonia

Inferred drug relations via UMLS 73 / NDF-RT 51 :


Cochrane evidence based reviews: pneumonia

Genetic Tests for Pneumonia

Genetic tests related to Pneumonia:

# Genetic test Affiliating Genes
1 Pneumonia 29

Anatomical Context for Pneumonia

MalaCards organs/tissues related to Pneumonia:

41
Lung, Testes, Skin, Colon, Heart, Brain, Bone

Publications for Pneumonia

Articles related to Pneumonia:

(show top 50) (show all 8839)
# Title Authors Year
1
A successful treatment of rheumatoid arthritis-related interstitial pneumonia with nintedanib. ( 30533376 )
2019
2
Differences in clinical features of acute exacerbation between connective tissue disease-associated interstitial pneumonia and idiopathic pulmonary fibrosis. ( 30380910 )
2019
3
Impact of mental illness on outcomes of outpatients with community-acquired pneumonia. ( 30422835 )
2019
4
Early readmission and mortality in acute exacerbation of chronic obstructive pulmonary disease with community-acquired pneumonia. ( 30428701 )
2019
5
Global, regional, and national estimates of pneumonia morbidity and mortality in children younger than 5 years between 2000 and 2015: a systematic analysis. ( 30497986 )
2019
6
Global childhood pneumonia: the good news, the bad news, and the way ahead. ( 30497987 )
2019
7
The Effects of Oral Care Protocol on the Incidence of Ventilation-Associated Pneumonia in Selected Intensive Care Units in Jordan. ( 30499786 )
2019
8
Pasteurella multocida pneumonia with hemoptysis: A case report. ( 30510895 )
2019
9
The usefulness of serum procalcitonin, C-reactive protein, soluble triggering receptor expressed on myeloid cells 1 and Clinical Pulmonary Infection Score for evaluation of severity and prognosis of community-acquired pneumonia in elderly patients. ( 30366226 )
2019
10
Lung function improvements in emphysema following pneumonia. ( 30416955 )
2019
11
Round opacity as a presentation of pneumocystis jirovecii pneumonia in an HIV-infected patient. ( 30287130 )
2019
12
Urban climate modified short-term association of air pollution with pneumonia mortality in Hong Kong. ( 30059922 )
2019
13
Comparison of procalcitonin, C-reactive protein, white blood cell count and clinical status in diagnosing pneumonia in patients hospitalized with acute exacerbations of COPD: A prospective observational study. ( 29848051 )
2019
14
Non-invasive ventilation in community acquired pneumonia. ( 29848458 )
2019
15
Non-invasive ventilation in patients with community acquired pneumonia in the emergency department: Author's response. ( 29859644 )
2019
16
The risk stratification in community-acquired pneumonia. ( 29861369 )
2019
17
Systematic dysphagia screening and dietary modifications to reduce stroke-associated pneumonia rates in a stroke-unit. ( 29389984 )
2018
18
Effect of starting oral intake on weekends on the clinical course of patients with aspiration pneumonia. ( 29780243 )
2018
19
Synthetic avenues towards a tetrasaccharide related to <i>Streptococcus pneumonia</i> of serotype 6A. ( 29977381 )
2018
20
Prevalence and impact of WHO group 3 pulmonary hypertension in advanced idiopathic nonspecific interstitial pneumonia. ( 29773690 )
2018
21
A Randomized Controlled Trial to Investigate the Effectiveness of the Prevention of Aspiration Pneumonia Using Recommendations for Swallowing Care Guided by Ultrasound Examination. ( 29439537 )
2018
22
Purulent pericarditis, an unusual complication of pneumococcal pneumonia: a case report. ( 29322942 )
2018
23
Common variable immunodeficiency presenting in a man with recurrent pneumonia caused by <i>Staphylococcus lugdunensis</i>. ( 29559491 )
2018
24
Bronchiolitis obliterans organizing pneumonia after stereotactic ablative radiation therapy for lung cancer: A case report. ( 29395853 )
2018
25
Combined pharmacotherapy for osteonecrosis of the femoral head after severe acute respiratory syndrome and interstitial pneumonia: two and a half to fourteenA year follow-up. ( 29594456 )
2018
26
Association of serum high-mobility group box protein 1 level with outcomes of acute exacerbation of idiopathic pulmonary fibrosis and fibrosing nonspecific interstitial pneumonia. ( 29795561 )
2018
27
Bronchiolitis obliterans organising pneumonia as an initial manifestation in a patient with systemic lupus erythematosus: a rare presentation. ( 29804073 )
2018
28
Legionella Pneumonia Complicated with Acquired Fanconi Syndrome: A Case Report. ( 29877286 )
2018
29
Aspiration pneumonia induces muscle atrophy in the respiratory, skeletal, and swallowing systems. ( 29790300 )
2018
30
Systemic scleroderma-related interstitial pneumonia associated with borderline pulmonary arterial hypertension. ( 29804068 )
2018
31
Reply to the letter: &amp;quot;Pericardial effusion in community-acquired pneumonia: casuality or etiology?&amp;quot; ( 29735269 )
2018
32
Invasive pulmonary aspergillosis mimicking organizing pneumonia after mTOR inhibitor therapy: a case report. ( 29408183 )
2018
33
Osteoblasts Are Rapidly Ablated by Virus-Induced Systemic Inflammation following Lymphocytic Choriomeningitis Virus or Pneumonia Virus of Mice Infection in Mice. ( 29212906 )
2018
34
Using oral health assessment to predict aspiration pneumonia in older adults. ( 29446124 )
2018
35
Pulmonary Adenocarcinoma Mimicking Desquamative Interstitial Pneumonia: Report of 2 Cases With Genetic Analysis. ( 29720004 )
2018
36
Tigecycline application in a 3-month-old infant with multiple drug resistant <i>Klebsiella pneumonia</i>: a case report. ( 29977345 )
2018
37
Pneumomediastinum and Pneumothorax Associated with Herpes Simplex Virus (HSV) Pneumonia. ( 29379004 )
2018
38
Whole-genome sequence analysis of<i>Streptococcus pneumoniae</i>strains that cause hospital-acquired pneumonia infections. ( 29444837 )
2018
39
Severe pneumonia associated with ibrutinib monotherapy for CLL and lymphoma. ( 28156016 )
2018
40
Treating nosocomial pneumonia: what's new. ( 29978856 )
2018
41
Comparison of Videofluoroscopic Swallowing Study and Radionuclide Salivagram for Aspiration Pneumonia in Children With Swallowing Difficulty. ( 29560324 )
2018
42
A Serological Biomarker of Versican Degradation is Associated with Mortality Following Acute Exacerbations of Idiopathic Interstitial Pneumonia. ( 29728109 )
2018
43
Maternal Influenza Immunization and Prevention of Severe Clinical Pneumonia in Young Infants: Analysis of Randomized Controlled Trials Conducted in Nepal, Mali, and South Africa. ( 29443825 )
2018
44
Pre-stroke undiagnosed dysphagia lusoria as a rare cause of aspiration pneumonia with respiratory failure in a stroke patient. ( 29552342 )
2018
45
Community-acquired bacterial pneumonia in adult HIV-infected patients. ( 29976111 )
2018
46
Serial chest CT in cryptogenic organizing pneumonia: Evolutional changes and prognostic determinants. ( 28960643 )
2018
47
Empirical antibiotic treatment for children suffering from dysentery, cholera, pneumonia, sepsis or severe acute malnutrition. ( 29790843 )
2018
48
Acute eosinophilic pneumonia in the deployed military setting. ( 29605194 )
2018
49
One-Year Risk of Pneumonia and Mortality in Patients with Poststroke Dysphagia: A Nationwide Population-Based Study. ( 29395642 )
2018
50
Ventilator associated pneumonia caused by <i>Raoultella ornithinolytica</i> in two immunocompetent trauma patients. ( 29977781 )
2018